FzioMed, Inc. (FzioMed) is a medical device manufacturing company. The company is principally engaged in manufacturing, development, marketing and sale of absorbable, surgical biomaterials in the area of orthopedics, general surgery, and aesthetic surgery. Its product portfolio includes oxiplex/sp gel, medishield - adhesion barriers for spine surgery, laresse dermal filler and ethicon intercoat absorable adhesion barrier Gel. It offers its products to hospitals, clinics, surgery centers, physician offices, nursing homes, long-term care facilities, home health care, and retail health care. Additionally, the company also conducts clinical trials. The company focuses on research and development activities for the development of new technologies and products. FzioMed is headquartered in California, the US.